Tag: Jewish

News

10/18/11

Previous appendectomy linked to cancer in Jewish BRCA carriers

Studies

• Pathogenic BRCA Variants in the Ashkenazi Jewish Population: A Retrospective Study [ID 2683559] Cite
  Barkan S, Kuizon CM, Ruiz-Pelaez JG, Etkin-Kramer E. Pathogenic BRCA Variants in the Ashkenazi Jewish Population: A Retrospective Study [ID 2683559]. Obstetrics & Gynecology. Ovid Technologies (Wolters Kluwer Health); 2024; 143:73S-73S 10.1097/01.aog.0001013960.08426.ef
• Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel Cite
  Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, et al. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. BMJ; 2023;:jmg-2023-109185 10.1136/jmg-2023-109185
• Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea Cite
  Liu N, Yang D, Wu Y, Xue W, Li D, Zhang J, et al. Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea. BMC Cancer. Springer Science and Business Media LLC; 2022; 22 10.1186/s12885-022-09923-4
• Rate of breast biopsy referrals in BRCA mutation carriers: a retrospective comparative study and matched analysis Cite
  Pomerantz A, Tsoref D, Grubstein A, Wadhawker S, Rapson Y, Gadiel I, et al. Rate of breast biopsy referrals in BRCA mutation carriers: a retrospective comparative study and matched analysis. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-670565/v1
• Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy Cite
  Michaelson-Cohen R, Gabizon–Peretz S, Armon S, Srebnik-Moshe N, Mor P, Tomer A, et al. Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy. European Journal of Cancer. Elsevier BV; 2021; 148:95-102 10.1016/j.ejca.2021.02.007
• Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms Cite
  Bernstein-Molho R, Singer A, Laitman Y, Netzer I, Zalmanoviz S, Friedman E. Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 176:165-170 10.1007/s10549-019-05228-6
• Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center Cite
  Frey MK, Kopparam RV, Ni Zhou Z, Fields JC, Buskwofie A, Carlson AD, et al. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center. Cancer. Wiley; 2018; 125:690-697 10.1002/cncr.31856
• The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women Cite
  Rouach V, Goldshtein I, Buch A, Catane R, Chodick G, Stern N, et al. The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women. Journal of Bone Oncology. Elsevier BV; 2019; 16:100202 10.1016/j.jbo.2018.10.001
• The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations Cite
  Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, et al. The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:151-157 10.1007/s10549-018-4887-7
• Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women Cite
  Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, et al. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women. JAMA Oncology. American Medical Association (AMA); 2017; 3:1647 10.1001/jamaoncol.2017.1996
• Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men Cite
  Keinan‐Boker L, Levine H, Leiba A, Derazne E, Kark JD. Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men. International Journal of Cancer. Wiley; 2017; 142:910-918 10.1002/ijc.31121
• Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes Cite
  Frey MK, Sandler G, Sobolev R, Kim SH, Chambers R, Bassett RY, et al. Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes. Gynecologic Oncology. Elsevier BV; 2017; 146:123-128 10.1016/j.ygyno.2017.04.009
• Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up Cite
  Dagan E, Gershoni-Baruch R, Kurolap A, Fried G. Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up. European Journal of Cancer Care. Wiley; 2016; 26:e12594 10.1111/ecc.12594
• Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women Cite
  Keinan-Boker L, Levine H, Derazne E, Molina-Hazan V, Kark JD. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 158:157-167 10.1007/s10549-016-3860-6
• Screening for breast cancer by molecular testing for three founder mutations in the BRCA1 and BRCA2 genes among women of Ashkenazi Jewish heritage Cite
  Palomaki GE. Screening for breast cancer by molecular testing for three founder mutations in the BRCA1 and BRCA2 genes among women of Ashkenazi Jewish heritage. Journal of Medical Screening. SAGE Publications; 2015; 22:109-111 10.1177/0969141315579701
• Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience Cite
  Asleh-Aburaya K, Fried G. Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience. SpringerPlus. Springer Science and Business Media LLC; 2015; 4 10.1186/s40064-015-0900-3
• World War II-related post-traumatic stress disorder and breast cancer risk among Israeli women: a case-control study Cite
  Vin-Raviv N, Dekel R, Barchana M, Linn S, Keinan-Boker L. World War II-related post-traumatic stress disorder and breast cancer risk among Israeli women: a case-control study. International Psychogeriatrics. Cambridge University Press (CUP); 2013; 26:499-508 10.1017/s1041610213002081
• Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation Cite
  Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, et al. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Human Genetics. Springer Science and Business Media LLC; 2013; 132:523-536 10.1007/s00439-013-1269-4
• Severe caloric restriction in young women during World War II and subsequent breast cancer risk Cite
  Vin-Raviv N, Barchana M, Linn S, Keinan-Boker L. Severe caloric restriction in young women during World War II and subsequent breast cancer risk. International Journal of Clinical Practice. Wiley; 2012; 66:948-958 10.1111/j.1742-1241.2012.02966.x
• Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? Cite
  Bernholtz S, Laitman Y, Kaufman B, Shimon-Paluch S, Friedman E. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:669-673 10.1007/s10549-011-1886-3
• Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers Cite
  Bernholtz S, Jakobson-Setton A, Korach J, Ben Baruch G, Laitman Y, Friedman E. Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:981-985 10.1007/s10549-011-1807-5
• Does the Modern Urbanized Sleeping Habitat Pose a Breast Cancer Risk? Cite
  Kloog I, Portnov BA, Rennert HS, Haim A. Does the Modern Urbanized Sleeping Habitat Pose a Breast Cancer Risk?. Chronobiology International. Informa UK Limited; 2010; 28:76-80 10.3109/07420528.2010.531490
• Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women Cite
  Metcalfe KA, Poll A, Royer R, Llacuachaqui M, Tulman A, Sun P, et al. Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:387-391 10.1200/jco.2009.25.0712
• The association between breastfeeding and breast cancer occurrence among Israeli Jewish women: a case control study Cite
  Shema L, Ore L, Ben-Shachar M, Haj M, Linn S. The association between breastfeeding and breast cancer occurrence among Israeli Jewish women: a case control study. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2007; 133:539-546 10.1007/s00432-007-0199-8